This new 25,000 square foot facility is designed to accommodate a range of temperature-sensitive products that are being shipped in and out of the Northeastern pharmaceutical corridor of the US.
Included within the new building will be space for a controlled room temperature passive shipments facility that will operate at 15-25ºC. In addition, a refrigerated area will be available for shipments that need to be maintained in a 2-8ºC environment. Furthermore, a deep frozen area will cater to shipments requiring to be kept at -20 to -10ºC, as well as a zoned active container area with powered charging stations with space for up to 30 electronically-controlled units.
The facility is expected to be completed later in the year and will be equipped with technology for monitoring products with pro-active alarming. There will also be full back-up power generation to ensure product protection in the event of a power failure.
The opening of the Philadelphia pharmaceutical facility will coincide with the roll-out of a full ExpediteTC cold chain program across the entire AA network.
